Interpace Biosciences Inc
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $13.1M
Liabilities Breakdown FY2023
Total Liabilities: $22.1M
Asset Breakdown
Total Assets: $13.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.5M | 26.7% |
| Accounts Receivable | $5.1M | 38.7% |
| Inventory | $1.2M | 9.4% |
| Property, Plant & Equipment | $790.0K | 6.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.5M | 19.2% |
Liabilities Breakdown
Total Liabilities: $22.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 7.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $20.6M | 93.0% |